Positional gene expression analysis identifies 12q overexpression and amplification in a subset of neuroblastomas
- 1 October 2004
- journal article
- Published by Elsevier in Cancer Genetics and Cytogenetics
- Vol. 154 (2), 131-137
- https://doi.org/10.1016/j.cancergencyto.2004.02.009
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Experience with International Neuroblastoma Staging System and Pathology ClassificationBritish Journal of Cancer, 2002
- Molecular Genetics of Neuroblastoma and the Implications for Clinical Management: A Review of the MSKCC ExperienceThe Oncologist, 2001
- Survival analysis of clinical, pathologic, and genetic features in neuroblastoma presenting as locoregional diseaseCancer, 2001
- The current contribution of molecular factors to risk estimation in neuroblastoma patientsEuropean Journal Of Cancer, 1997
- Survival from non-stage 4 neuroblastoma without cytotoxic therapy: an analysis of clinical and biological markersEuropean Journal Of Cancer, 1997
- Patterns of oncogene activation in human neuroblastoma cellsJournal of Neuro-Oncology, 1997
- Regression and progression in neuroblastoma. Does genetics predict tumour behaviour?European Journal Of Cancer, 1995
- Cytogenetic evolution of mycn and mdm2 amplification in the neuroblastoma ls tumour and its cell lineEuropean Journal Of Cancer, 1995
- Identification of two distinct chromosome 12-derived amplification units in neuroblastoma cell line NGPCancer Genetics and Cytogenetics, 1995
- Neuroblastoma: Effect of genetic factors on prognosis and treatmentCancer, 1992